Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
05/29/1996 | CN1123275A Substituted chinolin derivative, preparation and application of same |
05/29/1996 | CN1123144A 3-substituted-2-oxindoles as inhibitors of viral replication |
05/28/1996 | US5521310 Process to obtain benzoxazines to be used for the synthesis of ofloxazine, levofloxazine and derivatives |
05/28/1996 | US5521308 Process for the preparation of crystalline TACA |
05/28/1996 | US5521307 Methods and compounds for the preparation of carbacephems |
05/28/1996 | US5521219 Treatment of aids |
05/28/1996 | US5521194 Antiproliferative agent for restenosis treatment |
05/28/1996 | US5521155 Antibiotic active against grampositive bacteria |
05/28/1996 | US5521082 Solvent extraction, precipitation, gel filtration, ion exchanging, vaccines |
05/28/1996 | US5521072 Vaccines |
05/28/1996 | US5520920 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
05/28/1996 | CA2072573C Treatment of human retroviral infections with 2',3'-dideoxyinosine |
05/23/1996 | WO1996015247A1 Purified papillomavirus proteins |
05/23/1996 | WO1996015241A2 A polynucleotide tuberculosis vaccine |
05/23/1996 | WO1996015238A1 Targeted t lymphocytes |
05/23/1996 | WO1996015234A2 Lipid-splitting enzyme |
05/23/1996 | WO1996015143A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
05/23/1996 | WO1996015131A1 Macrocyclic lactone compounds and their production process |
05/23/1996 | WO1996015130A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials |
05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
05/23/1996 | WO1996014863A1 Suppression of proteolytic activity by dysfunctional protease formation |
05/23/1996 | WO1996014860A1 Process for identifying para cation channel modulators |
05/23/1996 | WO1996014847A1 Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7) |
05/23/1996 | WO1996014831A1 Adjuvant for a vaccine composition |
05/23/1996 | WO1996014737A1 Treating red blood cell solutions with anti-viral agents |
05/23/1996 | WO1996012020A3 Hemoglobin receptors from neisseriae |
05/23/1996 | WO1996010580A3 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
05/23/1996 | CA2205414A1 Novel tumor suppressor gene, hic-1 |
05/23/1996 | CA2204908A1 Lipid cleavage enzyme |
05/23/1996 | CA2204597A1 Suppression of proteolytic activity by dysfunctional protease formation |
05/23/1996 | CA2203934A1 Targeted t lymphocytes |
05/23/1996 | CA2203565A1 Synthesis of peptide nucleic acids (pnas) and analogues via submonomer approach |
05/22/1996 | EP0712936A1 Low-molecular dna from sturgeon mult, a method of obtaining the dna and a pharmaceutical preparation based on it |
05/22/1996 | EP0712926A2 Fish pancreatic disease virus |
05/22/1996 | EP0712631A2 Cyclosporin containing multiple emulsions |
05/22/1996 | EP0712405A1 Derivatives of monic acids a and c having antibacterial, antimycoplasmatical, antifungal and herbicidal activity |
05/22/1996 | EP0677056B1 Oligonucleotide alkylphosphonates and alkylphosphonothioates |
05/22/1996 | EP0521914B1 A method for regulating neuron development and maintenance |
05/22/1996 | CN1122804A 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative |
05/22/1996 | CN1122803A Benzoxazolyl- and benzothiazolyloxazolidinones |
05/22/1996 | CN1031825C Process for preparing heteroaroyl derivatives of monocyclic beta-lactam antibiotics |
05/21/1996 | US5519126 Combatting diseases by biochemicl intervention at the rna and dna level |
05/21/1996 | US5519115 Reverse antimicrobial peptides |
05/21/1996 | US5519114 Retroviral superantigens, superantigen peptides, and methods of use |
05/21/1996 | US5519056 Fungicides against candida or aspergillus |
05/21/1996 | US5519028 Antiviral preparations |
05/21/1996 | US5519016 Aryl group- or aromatic heterocyclic group-substituted aminoquinolone derivatives and anti-HIV agent |
05/21/1996 | US5519015 Bactericides |
05/21/1996 | US5518723 Vaccines containing antibodies and epitopes |
05/17/1996 | WO1996014418A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
05/17/1996 | WO1996014393A1 H. pylori fermentation process |
05/17/1996 | WO1996014330A1 Amino acid nucleic acids |
05/17/1996 | WO1996014329A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
05/17/1996 | WO1996014328A1 Tumor necrosis factor-gamma |
05/17/1996 | WO1996014327A1 Antifungal sordaridin derivatives |
05/17/1996 | WO1996014326A1 Antifungal sordaridin derivatives |
05/17/1996 | WO1996014314A2 Thiepane compounds inhibiting and detecting hiv protease |
05/17/1996 | WO1996014088A1 Attenuated canine parvovirus vaccine |
05/17/1996 | WO1996014073A1 Treatment of urogenital cancer with boron neutron capture therapy |
05/17/1996 | WO1996014065A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
05/17/1996 | WO1996010419A3 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
05/17/1996 | WO1996007392A3 Oligonucleotide prodrugs |
05/17/1996 | CA2689871A1 Combined meningitis vaccine |
05/17/1996 | CA2307311A1 Sugar modified nucleosides and their use for synthesis of oligonucleotides |
05/17/1996 | CA2204618A1 Respiratory syncytial virus protein g expressed on bacterial membrane |
05/17/1996 | CA2204361A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
05/17/1996 | CA2204276A1 H. pylori fermentation process |
05/17/1996 | CA2203570A1 Thiepane compounds inhibiting and detecting hiv protease |
05/17/1996 | CA2202274A1 Amino acid nucleic acids |
05/17/1996 | CA2179403A1 Antifungal sordaridin derivatives |
05/15/1996 | EP0711829A2 Recombinant alphavirus vectors |
05/15/1996 | EP0711785A1 Novel antitumor antibiotic compounds: hayumicins and analogs thereof |
05/15/1996 | EP0711783A1 Antifungal Sordarin derivatives |
05/15/1996 | EP0711774A1 Crystalline cephem-addition salts and process for their preparation |
05/15/1996 | EP0711771A2 Substituted-1,3-oxathiolanes with antiviral properties |
05/15/1996 | EP0711563A1 Novel Borrelia vaccine |
05/15/1996 | EP0711557A1 Base for formulating pharmaceutical agents |
05/15/1996 | EP0711556A1 Intravenous solutions containing staurosporine derivatives |
05/15/1996 | EP0711555A2 Enzyme inactivators |
05/15/1996 | EP0711350A1 Clavulanic acid dehydrogenase, preparation and use for the production of clavulanic acid |
05/15/1996 | EP0711340A1 High yielding influenza viruses |
05/15/1996 | EP0711310A1 Human antibodies against varicella-zoster virus |
05/15/1996 | EP0711307A1 Peptides for neutralizing the toxicity of lipid a |
05/15/1996 | EP0711305A1 Protegrins |
05/15/1996 | EP0711301A1 Processes and intermediates for phosphorous-containing covalent linkages |
05/15/1996 | EP0711297A1 Rapamycin derivative with antimicrobial, anticancer and immunomodulation activity |
05/15/1996 | EP0711282A1 Compounds as pde iv and tnf inhibitors |
05/15/1996 | EP0711275A1 (thio)carbimidinic acid derivatives and medicaments containing the same |
05/15/1996 | EP0711170A1 T-lymphocyte-containing pharmaceutical composition for treating infections |
05/15/1996 | EP0711168A1 Methods of treating apoptosis and associated conditions |
05/15/1996 | EP0711165A1 Use of quinoline-3-carboxamide compounds for inhibiting the production of tumour necrosis factor (tnf) and/or for the treatment of septic shock |
05/15/1996 | EP0711163A1 Use of benzydamine in the treatment of pathological conditions caused by tnf |
05/15/1996 | EP0711160A1 Method of inhibiting the replication of human immunodeficiency viruses with substituted azaspiranes |
05/15/1996 | EP0711140A1 Antifungal nail solution |
05/15/1996 | EP0679153A4 Amino acids and peptides having modified terminals. |
05/15/1996 | EP0563389B1 Pharmaceutical aerosol preparation and its use for treatment and prophylaxis of viral diseases |
05/15/1996 | EP0465565B1 Treatment of aids dementia, myelopathy and blindness |
05/15/1996 | CN1122600A Second messenger cell signaling inhibitors |
05/15/1996 | CN1122576A Therapeutic strategies for immunoinfective cluster virus infections |